Matsui T, Kimura I, Kimura M
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan.
Jpn J Pharmacol. 1990 Oct;54(2):97-103. doi: 10.1254/jjp.54.97.
Acetylcholinesterase activity and pseudocholinesterase activity were examined in plasma and in striated muscles (whole heart and diaphragm muscles) of diabetic KK-CAy mice. Both activities of acetylcholinesterase in heart muscle and pseudocholinesterase in plasma were significantly increased in diabetic KK-CAy mice compared to pre-diabetic KK-CAy mice. Both acetylcholinesterase and pseudocholinesterase activities in skeletal muscle were not changed by the diabetic state. The increases in activity of plasma pseudocholinesterase was significantly correlated to the increase in blood glucose level in alloxan-, streptozotocin (STZ)-diabetic ddY mice and diabetic KK-CAy mice. The increase was not correlated to the body weight in non-diabetic female-KK-CAy mice. Furthermore, the activity of heart acetylcholinesterase was significantly correlated with the activity of plasma pseudocholinesterase (r = 0.79, P less than 0.01). The activities of acetylcholinesterases in heart muscles from STZ- and alloxan-diabetic ddY mice also tended to increase. The hypersensitivity of the pulse rate to a low dose (1 mg/kg) of acetylcholine was correlated to the activity of plasma pseudocholinesterase (r = -0.51, P less than 0.05). These results demonstrate that the activities of plasma pseudocholinesterase were increased by the diabetic state being associated with the increasing alteration of cardiac sensitivity to acetylcholine in the whole body.
对糖尿病KK-CAy小鼠的血浆以及横纹肌(全心和膈肌)中的乙酰胆碱酯酶活性和假性胆碱酯酶活性进行了检测。与糖尿病前期的KK-CAy小鼠相比,糖尿病KK-CAy小鼠心肌中的乙酰胆碱酯酶活性和血浆中的假性胆碱酯酶活性均显著增加。骨骼肌中的乙酰胆碱酯酶和假性胆碱酯酶活性均未因糖尿病状态而改变。在四氧嘧啶、链脲佐菌素(STZ)诱导的糖尿病ddY小鼠和糖尿病KK-CAy小鼠中,血浆假性胆碱酯酶活性的增加与血糖水平的升高显著相关。在非糖尿病雌性KK-CAy小鼠中,该增加与体重无关。此外,心脏乙酰胆碱酯酶活性与血浆假性胆碱酯酶活性显著相关(r = 0.79,P < 0.01)。来自STZ和四氧嘧啶诱导的糖尿病ddY小鼠心肌中的乙酰胆碱酯酶活性也有增加的趋势。脉搏率对低剂量(1 mg/kg)乙酰胆碱的超敏反应与血浆假性胆碱酯酶活性相关(r = -0.51,P < 0.05)。这些结果表明,糖尿病状态会使血浆假性胆碱酯酶活性增加,这与全身心脏对乙酰胆碱敏感性的改变增加有关。